全文获取类型
收费全文 | 11654篇 |
免费 | 663篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 193篇 |
儿科学 | 626篇 |
妇产科学 | 150篇 |
基础医学 | 1424篇 |
口腔科学 | 196篇 |
临床医学 | 859篇 |
内科学 | 2352篇 |
皮肤病学 | 220篇 |
神经病学 | 720篇 |
特种医学 | 242篇 |
外科学 | 1878篇 |
综合类 | 277篇 |
一般理论 | 8篇 |
预防医学 | 770篇 |
眼科学 | 386篇 |
药学 | 1173篇 |
中国医学 | 55篇 |
肿瘤学 | 814篇 |
出版年
2023年 | 82篇 |
2022年 | 250篇 |
2021年 | 465篇 |
2020年 | 272篇 |
2019年 | 348篇 |
2018年 | 403篇 |
2017年 | 259篇 |
2016年 | 350篇 |
2015年 | 382篇 |
2014年 | 505篇 |
2013年 | 574篇 |
2012年 | 857篇 |
2011年 | 868篇 |
2010年 | 484篇 |
2009年 | 418篇 |
2008年 | 679篇 |
2007年 | 685篇 |
2006年 | 683篇 |
2005年 | 560篇 |
2004年 | 532篇 |
2003年 | 465篇 |
2002年 | 364篇 |
2001年 | 205篇 |
2000年 | 170篇 |
1999年 | 156篇 |
1998年 | 100篇 |
1997年 | 61篇 |
1996年 | 66篇 |
1995年 | 39篇 |
1994年 | 43篇 |
1993年 | 57篇 |
1992年 | 85篇 |
1991年 | 66篇 |
1990年 | 56篇 |
1989年 | 88篇 |
1988年 | 80篇 |
1987年 | 53篇 |
1986年 | 53篇 |
1985年 | 43篇 |
1984年 | 43篇 |
1983年 | 50篇 |
1982年 | 21篇 |
1981年 | 22篇 |
1980年 | 31篇 |
1979年 | 25篇 |
1975年 | 24篇 |
1973年 | 29篇 |
1972年 | 22篇 |
1971年 | 20篇 |
1970年 | 30篇 |
排序方式: 共有10000条查询结果,搜索用时 234 毫秒
1.
2.
3.
4.
5.
Harit Kapoor Kush Raj Lohani Tommy H. Lee Devendra K. Agrawal Sumeet K. Mittal 《CTS Clinical and Translational Science》2015,8(6):841-847
Esophageal adenocarcinoma is the fastest rising cancer in the United States. It develops from long‐standing gastroesophageal reflux disease which affects >20% of the general population. It carries a very poor prognosis with 5‐year survival <20%. The disease is known to sequentially progress from reflux esophagitis to a metaplastic precursor, Barrett''s esophagus and then onto dysplasia and esophageal adenocarcinoma. However, only few patients with reflux develop Barrett''s esophagus and only a minority of these turn malignant. The reason for this heterogeneity in clinical progression is unknown. To improve patient management, molecular changes which facilitate disease progression must be identified. Animal models can provide a comprehensive functional and anatomic platform for such a study. Rats and mice have been the most widely studied but disease homology with humans has been questioned. No animal model naturally simulates the inflammation to adenocarcinoma progression as in humans, with all models requiring surgical bypass or destruction of existing antireflux mechanisms. Valuable properties of individual models could be utilized to holistically evaluate disease progression. In this review paper, we critically examined the current animal models of Barrett''s esophagus, their differences and homologies with human disease and how they have shaped our current understanding of Barrett''s carcinogenesis. 相似文献
6.
7.
Sadanandavalli Retnaswami Chandra Pawan Raj Thomas Gregor Issac 《Indian journal of dermatology》2015,60(3):290-292
Neurodegeneration with brain iron accumulation (NBIA) is the term applied to a heterogeneous group of disorders resulting in iron deposition in the basal ganglia. Well-known phenotypic features are progressive regression with extra pyramidal involvement and a variable course. A 10-year-old child born to consanguineous parents presented with progressive generalized opisthotonic dystonia, retrocollis, oromandibular dyskinesias, apraxia for swallowing, optic atrophy and severe self-mutilation of lips. MR imaging showed brain iron accumulation. Other causes of self-mutilation were excluded. Early infantile onset, ophisthotonic dystonia with oromandibular dyskinesias and characteristic MR images are suggestive of NBIA. There is only one case reported in the literature of self-mutilation in this condition. 相似文献
8.
Joseph F. Levy Rahul Khairnar Alexander V. Louie Timothy N. Showalter C. Daniel Mullins Mark V. Mishra 《Practical radiation oncology》2019,9(2):e172-e179
Purpose
A hydrogel rectal spacer (HRS) is a medical device that is approved by the U.S. Food and Drug Administration to increase the separation between the prostate and rectum. We conducted a cost-effectiveness analysis of HRS use for reduction in radiation therapy (RT) toxicities in patients with prostate cancer (PC) undergoing external beam RT (EBRT).Methods and Materials
A multistate Markov model was constructed from the U.S. payer perspective to examine the cost-effectiveness of HRS in men with localized PC receiving EBRT (EBRT alone vs EBRT + HRS). The subgroups analyzed included site of HRS placement (hospital outpatient, physician office, ambulatory surgery center) and proportion of patients with good baseline erectile function (EF). Data on EF, gastrointestinal and genitourinary toxicities incidence, and potential risks associated with HRS implantation were obtained from a recently published randomized clinical trial. Health utilities and costs were derived from the literature and the 2018 Physician Fee Schedule and were discounted 3% annually. Quality-adjusted life years (QALYs) and costs were modeled for a 5-year period from receipt of RT. Probabilistic sensitivity analysis and value-based threshold analyses were conducted.Results
The per-patient 5-year incremental cost for spacers administered in a hospital outpatient setting was $3578, and the incremental effectiveness was 0.0371 QALYs. The incremental cost-effectiveness ratio was $96,440/QALY for patients with PC undergoing HRS insertion in a hospital and $39,286/QALY for patients undergoing HRS insertion in an ambulatory facility. For men with good baseline EF, the incremental cost-effectiveness ratio was $35,548/QALY and $9627/QALY in hospital outpatient and ambulatory facility settings, respectively.Conclusions
Based on the current Medicare Physician Fee Schedule, HRS is cost-effective at a willingness to pay threshold of $100,000. These results contain substantial uncertainty, suggesting more evidence is needed to refine future decision-making. 相似文献9.
10.
Metabolic abnormalities of gastrointestinal mucosa in celiac disease: An in vitro proton nuclear magnetic resonance spectroscopy study
下载免费PDF全文
![点击此处可从《Journal of gastroenterology and hepatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)